Bioclinica Imaging Platform
The Bioclinica Imaging Platform leverages our in-house medical expertise to increase accuracy, reduce costs, and model the complexity of your clinical trial protocols. Our proprietary imaging systems enable the flexibility to design your workflow and analysis to meet your unique needs. Using our dedicated engineering teams, you eliminate the extra layers of cost and time associated with relying on third-party systems.
In-House Medical Expertise
Bioclinica is the world’s leading Imaging Core Lab with more than 30 full-time physicians and 35 doctoral-level scientists dedicated to medical imaging. Our decades of experience in assessing and reviewing medical images have informed the development path of our proprietary imaging systems. Bioclinica’s SMART Submit application incorporates this expertise every step of the way, from the second it screens a medical image for errors at the hospital to the final image interpretation. This precision derives from our commitment to being the top medical-scientific imaging experts in the field today.
Bespoke Workflows and Image Analysis Functions
Most core labs rely on third-party imaging applications designed for clinical patient care. Because these systems often have limited functionality, they require customization that is not only costly but can also delay your study. Bioclinica employs over 250 engineering staff dedicated to developing our proprietary imaging workstations, which feature segmentation algorithms, novel workflows, and custom reporting methods. Our Imaging Platform is designed to reflect the complexity of your protocol. This includes the ability to reconcile images against EDC data within our system or export it for import into a third-party EDC and view your images online.
Artificial intelligence: acceleration and accuracy
Bioclinica’s proprietary AI tools draw from our library of over 10 million analyzed image datasets. The combination of our AI experts and proprietary platform is the perfect way to accelerate your imaging research. Whether you need to screen chest CT’s in immuno-oncology trials for the presence of undiagnosed COVID-19 infection or invent an automated scoring system for the severity of Crohn’s disease, our extensive AI capabilities are at your service.
Minimize costs and reduce delays
Increase accuracy and minimize inter-reader variability
Automatic QC processes result in a 6 to 48-fold reduction in common imaging issues such as submitting the wrong patient’s images or leaving in unredacted Protected Health Information (PHI).
AI acts as another set of eyes on every image read to increase the reader’s accuracy while minimizing inter-reader variability. Moreover, our imaging expertise and AI platform allow us to create and validate AI models looking for novel imaging biomarkers.
Pre-submission image screening is a critical step to reduce risk, lower costs, and avoid trial delays.
The Bioclinica Imaging Platform utilizes our SMART Submit technology to screen images while still at the research site. SMART Submit includes more than 150 rules to detect common submission errors such as duplicate images, visible PHI, incorrect imaging exams, incomplete data sets, and missing exam dates. Learn More about SMART Submit.